Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
This study has been completed.
Study NCT00213018 Information provided by Population Council
First Received: September 13, 2005 Last Updated: October 21, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Chlamydia Trachomatis
Neisseria Gonorrhoeae
Trichomonas Vaginitis
Syphilis
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Gonorrhea
Infection
Vaginitis
More general conditions related to this trial
Bacterial Infections
Genital Diseases, Female
Genital Diseases, Male
Gram-Negative Bacterial Infections
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mastigophora Infections
Neisseriaceae Infections
Parasitic Diseases
Protozoan Infections
Retroviridae Infections
RNA Virus Infections
Sarcomastigophora Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Bacterial
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Spirochaetales Infections
Treponemal Infections
Trichomonas Infections
Vaginal Diseases
Virus Diseases
Interventions listed in this trial
Carraguard (PC-515)
Sponsors listed in this trial
Population Council
Bill and Melinda Gates Foundation
Family Health International
National Institute of Allergy and Infectious Diseases (NIAID)
Medical Research Council, South Africa
University of Cape Town
University of Limpopo
United States Agency for International Development (USAID)
Back to top of Main Content
